CLYM
CLYM
NASDAQ · Biotechnology

Climb Bio Inc

$13.80
+0.16 (+1.17%)
As of Sep 22, 3:10 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +89.2% upside
Low Target $17.52
Average Target $26.11
High Target $31.20
Current Price $13.80
Current
$13.80
Target
$26.11
$17.52 $26.11 avg $31.20
Scenario Analysis
Bear Case
$17.52
27.0%
Low target
Base Case
$26.11
+89.2%
Avg target
Bull Case
$31.20
+126.1%
High target
Risk/Reward
4.7x
Highly favorable
Price in Context
52-Week High
$18.33
-24.7% from high
52-Week Low
$1.54
+796.1% from low
Target vs 52W High
$26.11
+42.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%